Working... Menu
Trial record 1 of 1 for:    MErCuRIC1
Previous Study | Return to List | Next Study

MEK and MET Inhibition in Colorectal Cancer (MErCuRIC1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02510001
Recruitment Status : Active, not recruiting
First Posted : July 28, 2015
Last Update Posted : November 27, 2018
Queen's University, Belfast
Oxford University Hospitals NHS Trust
Velindre NHS Trust
University Hospital, Antwerp
Hospital Vall d'Hebron
Saint Antoine University Hospital
European Georges Pompidou Hospital
University of Turin, Italy
Belfast Health and Social Care Trust
Beaumont Hospital
European Commission
Array BioPharma
University of Paris 5 - Rene Descartes
Information provided by (Responsible Party):
University of Oxford

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 2019
  Estimated Study Completion Date : September 2019